LENSAR Inc.

Sunshine Heart CEO Heart failure device developer Sunshine Heart Inc. appointed John Erb CEO effective March 2. Erb had been filling in as interim CEO after the departure of former chief David R

Demand in most segments of the ophthalmology surgery systems market, particularly for more cost-effective, minimally invasive surgical treatments, is set to remain strong in the US due to the aging po

Device Transactions Thirty-six financings brought in $1.2 billion during 2013’s fourth quarter, almost double Q3’s $644 million total, making it the most lucrative quarter of 2013. The majority (63%)

Each year, START-UP reviews the sectors of the medical device industry that received private funding to identify investment trends and to discover what will be fueling the growth of medtech strategi